000 01116 a2200313 4500
005 20250513090645.0
264 0 _c19960621
008 199606s 0 0 ger d
022 _a0723-5003
040 _aNLM
_beng
_cNLM
100 1 _aGerlach, M
245 0 0 _a[Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants].
_h[electronic resource]
260 _bMedizinische Klinik (Munich, Germany : 1983)
_cMar 1996
300 _a163-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xtherapeutic use
650 0 4 _aCentral Nervous System Diseases
_xphysiopathology
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNerve Degeneration
650 0 4 _aNeurons
_xmetabolism
650 0 4 _aNeuroprotective Agents
_xtherapeutic use
650 0 4 _aNeurotoxins
_xtoxicity
650 0 4 _aOxidative Stress
650 0 4 _aParkinson Disease
_xdrug therapy
700 1 _aRiederer, P
773 0 _tMedizinische Klinik (Munich, Germany : 1983)
_gvol. 91
_gno. 3
_gp. 163-70
999 _c8627248
_d8627248